Researchers from the National Centre for Drug Adherence Testing (NCAT) at Leicester’s Hospitals, together with colleagues at the University of Leicester, took urine samples from 228 patients taken at their annual diabetes review. The urine samples were screened for 60 different medicines used read more »

A report has revealed rapidly rising rates of autoimmune conditions are costing the UK billions each year. The report shows direct and indirect costs to the UK for just three autoimmune conditions alone – Type 1 diabetes, rheumatoid arthritis and multiple sclerosis read more »

Her Royal Highness with Professor Roman Hovorka at Addenbrookes Hospital. In November 2018, Her Royal Highness The Duchess of Cornwall visited Addenbrooke’s Hospital to see the world-leading type 1 diabetes technology being developed there by Professor Roman Hovorka of the University of Cambridge. The read more »

ViaCyte, a beta cell technology company funded by JDRF, has been awarded a Small Business Innovative Research (SBIR) Phase II Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support the further development of its work. In read more »

JDRF’s One Walks are taking place across the UK, giving you the chance to help raise money for Type 1 diabetes research. A global event to walk for the future of Type 1 diabetes research, One Walks began in 2014 and have read more »

The Ascensia Diabetes Challenge was launched last September. A global innovation competition, it was introduced to fine digital solutions to support Type 2 diabetes management. The many entries have been narrowed down to six that will progress to the finalist stage of read more »

As reported in Fierce Biotech, in America Semma Therapeutics has raised $114 million to take a potentially-curative Type 1 diabetes cell therapy through clinical proof of concept. The funding round positions Semma to start learning whether its insulin-producing cells can control blood read more »

Researchers at Leeds Beckett University are seeking volunteers with Type 1 diabetes to take part in a new study looking to determine whether omega-3 supplements can improve the day-to-day management of Type 1 diabetes. The study is led by Dr Matthew Campbell, read more »

Diabetes kit that’s coming soon: An interview with Dr. Philip Toleikis of Sernova Corp, based in London, Ontario, Canada about the company’s Cell Pouch and immune protected cell technologies, referred to as a regenerative medicine solution in development. The company’s stated aim read more »

The BiAP is the bio-inspired artificial pancreas. We have an update on progress of this British-based endeavour. Moving overseas, we have another research report on Cell Pouch technology being researched in Canada. This is an implantable matrix that can hold stem beta read more »